Indian drug companies develop versions of Wegovy

Indian drug companies have started developing their own versions of Novo Nordisk’s Wegovy. With some analysts predicting that the weight loss market will reach $100 billion a year or more by the end of the decade, executives at Sun Pharma, Cipla, Dr Reddy’s and Lupin say they have started work on versions of Wegovy.

Share This Post: